Previous close | 2.2100 |
Open | 2.2100 |
Bid | 2.2250 x N/A |
Ask | 2.4500 x N/A |
Day's range | 2.2100 - 2.2100 |
52-week range | 2.1500 - 3.4000 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Innate Pharma S.A. (NASDAQ:IPHA) Q4 2023 Earnings Call Transcript March 21, 2024 Innate Pharma S.A. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: At this time, I would like to welcome everyone to the Innate Pharma Full Year 2023 Financial […]
Innate Pharma (IPHA) stock moves up in the pre-market hours as the FDA lifts the partial clinical hold placed on a study evaluating lacutamab for Sezary syndrome.
Innate Pharma S.A. (NASDAQ:IPHA) Q3 2023 Earnings Call Transcript November 14, 2023 Operator: Thank you for standing by, and welcome to the Innate Pharma Third Quarter 2023 Financial Results and Business Update. I would now like to welcome Henry Wheeler, VP, Investor Relations and Communications, to begin the call. Henry, over to you. Henry Wheeler: […]